HomeBXP • LON
add
Beximco Pharmaceuticals GDR
Previous close
GBX 27.50
Day range
GBX 28.78 - GBX 32.40
Year range
GBX 19.33 - GBX 45.00
Avg Volume
133.06K
Financials
Income Statement
Revenue
Net income
(BDT) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 10.99B | 15.00% |
Operating expense | 2.91B | 6.08% |
Net income | 1.36B | 43.55% |
Net profit margin | 12.42 | 24.82% |
Earnings per share | — | — |
EBITDA | 2.39B | 20.10% |
Effective tax rate | 20.35% | — |
Balance Sheet
Total assets
Total liabilities
(BDT) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.73B | 31.78% |
Total assets | 70.22B | 2.00% |
Total liabilities | 19.81B | -10.82% |
Total equity | 50.41B | — |
Shares outstanding | 446.11M | — |
Price to book | 0.00 | — |
Return on assets | 6.71% | — |
Return on capital | 8.25% | — |
Cash Flow
Net change in cash
(BDT) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 1.36B | 43.55% |
Cash from operations | 2.13B | 10.16% |
Cash from investing | -344.37M | 27.43% |
Cash from financing | -1.72B | 0.25% |
Net change in cash | 64.61M | 124.59% |
Free cash flow | -84.91M | 65.09% |
About
Founded
1976
Headquarters
Website
Employees
1,324